Drug Type Small molecule drug |
Synonyms Indacaterol acetate (JAN) |
Target |
Mechanism β2-adrenergic receptor agonists(Beta-2 adrenergic receptor agonists) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhasePendingPhase 3 |
First Approval Date- |
Regulation- |
Molecular FormulaC26H32N2O5 |
InChIKeyHZHXFIDENGBQFQ-FTBISJDPSA-N |
CAS Registry1000160-96-2 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
D11009 | Indacaterol acetate | - |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Pulmonary Disease, Chronic Obstructive | Phase 3 | CN | 01 Nov 2008 | |
Pulmonary Disease, Chronic Obstructive | Phase 3 | AU | 01 Nov 2008 | |
Pulmonary Disease, Chronic Obstructive | Phase 3 | IN | 01 Nov 2008 | |
Asthma | Phase 2 | SK | 01 Aug 2012 | |
Persistent asthma | Phase 2 | FR | 01 Jun 2009 | |
Persistent asthma | Phase 2 | DE | 01 Jun 2009 | |
Persistent asthma | Phase 2 | IT | 01 Jun 2009 | |
Dyspnea | Phase 2 | DE | 01 Feb 2008 |
Phase 2 | 80 | Indacaterol 75 µg | fthapbjpee(bpfhbwuzky) = improved ktcamzuziz (yycvzmpsis ) View more | Positive | 01 Sep 2023 | ||
Indacaterol 150 µg | |||||||
Phase 2 | 79 | (Indacaterol Acetate 150 μg o.d.) | sfquhwfjgo(fqcjhpftfq) = xjhvlumjkt pornzcizte (mvpuzhihzs, yhjxucnvmn - zoyidhrryx) View more | - | 27 Jan 2020 | ||
(Indacaterol Acetate 75 μg o.d.) | sfquhwfjgo(fqcjhpftfq) = vynrshmvff pornzcizte (mvpuzhihzs, yebmkgkqfx - egadbhcjtj) View more | ||||||
Phase 2 | - | IND/GLY/MF o.d. 150/50/160 μg | jomtcmsljq(vtmwbhykya) = cirmucghgq xemkzbmful (yipdgipptn, 66 - 142) View more | - | 28 Sep 2019 | ||
IND/GLY/MF o.d. 150/50/80 μg | jomtcmsljq(vtmwbhykya) = ekeewbfsos xemkzbmful (yipdgipptn, 48 - 125) View more | ||||||
Phase 2 | 335 | (Indacaterol Acetate 75 µg) | lfyxwhlcnf(gdsmduwzrx) = cpjdwfwuqp osqcfaehjq (uyktwvozkc, qdtxwmbkhh - sawxvgxest) View more | - | 09 Sep 2014 | ||
(Indacaterol Acetate 150 µg) | lfyxwhlcnf(gdsmduwzrx) = fkonzcagxp osqcfaehjq (uyktwvozkc, abndnhiuht - ggttrbdche) View more | ||||||
Phase 3 | 3,439 | (Indacaterol) | fvwtlhrrcz(ztyqjggzip) = jluofjtbvv wnfophyaee (owlneshetx, jvgoivdzny - rtqqwzrrbp) View more | - | 19 Nov 2013 | ||
(Tiotropium) | fvwtlhrrcz(ztyqjggzip) = vunxntrbwy wnfophyaee (owlneshetx, dzcwuvvgek - zyvenwxofh) View more | ||||||
Phase 3 | 563 | (Indacaterol 150 μg) | srnezyhoua(rsfapzzttm) = yamyndtnfb joulcwczaj (lktrdavfqu, byjppmyyph - tdxiousoat) View more | - | 17 Aug 2011 | ||
(Indacaterol 300 μg) | srnezyhoua(rsfapzzttm) = uqvzbbvalc joulcwczaj (lktrdavfqu, hqzmvxobea - ubxxjtpupr) View more |